Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Laggard
(
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.3%. By the end of trading, Regeneron Pharmaceuticals fell $4.46 (-1.9%) to $229.02 on light volume. Throughout the day, 678,938 shares of Regeneron Pharmaceuticals exchanged hands as compared to its average daily volume of 1,258,800 shares. The stock ranged in price between $225.78-$235.99 after having opened the day at $234.81 as compared to the previous trading day's close of $233.48. Other companies within the Health Care sector that declined today were:
(
), down 70.1%,
(
), down 37.2%,
(
), down 20.0% and
(
), down 13.2%.
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. Regeneron Pharmaceuticals has a market cap of $22.3 billion and is part of the drugs industry. Shares are up 36.5% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and 6 rate it a hold.
TheStreet Ratings rates
Regeneron Pharmaceuticals
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Regeneron Pharmaceuticals Ratings Report.
On the positive front,
(
), up 20.1%,
(
), up 15.5%,
(
), up 14.3% and
(
), up 11.8% , were all gainers within the health care sector with
(
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null